Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs On-Q Catheter for Pain After Total Knee Arthroplasty
NCT02739230Completed
- Sponsor
- Rothman Orthopaedics
- Start
- Dec 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of bupivacaine in osteoarthritis (OA) (2 arms), sponsored by Rothman Orthopaedics. Primary endpoint: Total Morphine and morphine equivalent consumption at 96 hours. Started Dec 2013; status: completed.
02
Drugs
bupivacaine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02739230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02739230.